Skip to main content
Erschienen in: Calcified Tissue International 6/2010

01.06.2010

Administration of the Bisphosphonate Zoledronic Acid During Tooth Development Inhibits Tooth Eruption and Formation and Induces Dental Abnormalities in Rats

verfasst von: Toru Hiraga, Tadashi Ninomiya, Akihiro Hosoya, Hiroaki Nakamura

Erschienen in: Calcified Tissue International | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Bisphosphonates (BPs) are potent inhibitors of osteoclastic bone resorption and widely used for the treatment of osteoporosis and metastatic bone diseases. Recently, BPs have also been shown to benefit children with primary and secondary osteoporosis, including osteogenesis imperfecta; however, their long-term safety has not been established yet. Clinical and experimental studies have demonstrated that BPs delay or inhibit tooth eruption. The failure of tooth eruption causes several dental abnormalities. In this study, to determine the effects of BPs on tooth formation, the BP zoledronic acid (ZOL) was injected into 7- and 14-day-old rats, and the development of the mandibular teeth was examined. X-ray analysis demonstrated that ZOL inhibited the eruption of both incisors and molars and their formation, especially in the molar roots. Histological examination showed that, in ZOL-treated animals, alveolar bone remained unresorbed around tooth crowns, which injured ameloblasts and enamel matrix, leading to defects of the enamel. Furthermore, haphazard proliferation of odontogenic epithelium and mesenchyme associated with primitive tooth structures, which resembles human odontomas, was induced at the basal end of incisors but not around the molars. Tooth ankylosis to alveolar bone was occasionally observed in molars. These results suggest that administration of BPs during tooth development has the potential to inhibit tooth eruption and formation and to induce several types of dental abnormalities, which may be attributed to the altered osteoclastic activities.
Literatur
1.
Zurück zum Zitat Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032–1045CrossRefPubMed Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032–1045CrossRefPubMed
2.
Zurück zum Zitat Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209–257CrossRefPubMed Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209–257CrossRefPubMed
3.
Zurück zum Zitat Castillo H, Samson-Fang L (2009) Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. Dev Med Child Neurol 51:17–29CrossRefPubMed Castillo H, Samson-Fang L (2009) Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. Dev Med Child Neurol 51:17–29CrossRefPubMed
4.
Zurück zum Zitat Bachrach L, Ward L (2009) Bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab 94:400–409CrossRefPubMed Bachrach L, Ward L (2009) Bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab 94:400–409CrossRefPubMed
5.
Zurück zum Zitat Shaw NJ (2008) Management of osteoporosis in children. Eur J Endocrinol 159 Suppl 1:S33–S39CrossRefPubMed Shaw NJ (2008) Management of osteoporosis in children. Eur J Endocrinol 159 Suppl 1:S33–S39CrossRefPubMed
6.
Zurück zum Zitat ElNesr NM, Avery JK (2002) Tooth eruption and shedding. In: Avery JK (ed) Oral development and histology. Thieme, New York, pp 123–140 ElNesr NM, Avery JK (2002) Tooth eruption and shedding. In: Avery JK (ed) Oral development and histology. Thieme, New York, pp 123–140
7.
Zurück zum Zitat Wise G, King G (2008) Mechanisms of tooth eruption and orthodontic tooth movement. J Dent Res 87:414–434CrossRefPubMed Wise G, King G (2008) Mechanisms of tooth eruption and orthodontic tooth movement. J Dent Res 87:414–434CrossRefPubMed
8.
Zurück zum Zitat Kamoun-Goldrat A, Ginisty D, Le Merrer M (2008) Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta. Eur J Oral Sci 116:195–198CrossRefPubMed Kamoun-Goldrat A, Ginisty D, Le Merrer M (2008) Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta. Eur J Oral Sci 116:195–198CrossRefPubMed
9.
Zurück zum Zitat Hodgson B (2009) More about bisphosphonates. J Am Dent Assoc 140:829–830PubMed Hodgson B (2009) More about bisphosphonates. J Am Dent Assoc 140:829–830PubMed
10.
Zurück zum Zitat Bradaschia-Correa V, Massa L, Arana-Chavez V (2007) Effects of alendronate on tooth eruption and molar root formation in young growing rats. Cell Tissue Res 330:475–485CrossRefPubMed Bradaschia-Correa V, Massa L, Arana-Chavez V (2007) Effects of alendronate on tooth eruption and molar root formation in young growing rats. Cell Tissue Res 330:475–485CrossRefPubMed
11.
Zurück zum Zitat Grier RT, Wise G (1998) Inhibition of tooth eruption in the rat by a bisphosphonate. J Dent Res 77:8–15CrossRefPubMed Grier RT, Wise G (1998) Inhibition of tooth eruption in the rat by a bisphosphonate. J Dent Res 77:8–15CrossRefPubMed
12.
13.
Zurück zum Zitat Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693–702CrossRefPubMed Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693–702CrossRefPubMed
14.
Zurück zum Zitat Ida-Yonemochi H, Noda T, Shimokawa H, Saku T (2002) Disturbed tooth eruption in osteopetrotic (op/op) mice: histopathogenesis of tooth malformation and odontomas. J Oral Pathol Med 31:361–373CrossRefPubMed Ida-Yonemochi H, Noda T, Shimokawa H, Saku T (2002) Disturbed tooth eruption in osteopetrotic (op/op) mice: histopathogenesis of tooth malformation and odontomas. J Oral Pathol Med 31:361–373CrossRefPubMed
15.
Zurück zum Zitat Amling M, Neff L, Priemel M, Schilling A, Rueger J, Baron R (2000) Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice. Bone 27:603–610CrossRefPubMed Amling M, Neff L, Priemel M, Schilling A, Rueger J, Baron R (2000) Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice. Bone 27:603–610CrossRefPubMed
16.
Zurück zum Zitat Tiffee J, Xing L, Nilsson S, Boyce B (1999) Dental abnormalities associated with failure of tooth eruption in src knockout and op/op mice. Calcif Tissue Int 65:53–58CrossRefPubMed Tiffee J, Xing L, Nilsson S, Boyce B (1999) Dental abnormalities associated with failure of tooth eruption in src knockout and op/op mice. Calcif Tissue Int 65:53–58CrossRefPubMed
17.
Zurück zum Zitat Kawata T, Tokimasa C, Nowroozi N, Fujita T, Kaku M, Kawasoko S, Sugiyama H, Ozawa S, Zernik J, Tanne K (1999) Lack of the bone remodeling in osteopetrotic (op/op) mice associated with microdontia. J Craniofac Genet Dev Biol 19:113–117PubMed Kawata T, Tokimasa C, Nowroozi N, Fujita T, Kaku M, Kawasoko S, Sugiyama H, Ozawa S, Zernik J, Tanne K (1999) Lack of the bone remodeling in osteopetrotic (op/op) mice associated with microdontia. J Craniofac Genet Dev Biol 19:113–117PubMed
18.
Zurück zum Zitat Hiraga T, Nakamura H (2009) Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals. Int J Cancer 124:215–222CrossRefPubMed Hiraga T, Nakamura H (2009) Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals. Int J Cancer 124:215–222CrossRefPubMed
19.
Zurück zum Zitat Irie K, Ozawa H (1990) Relationships between tooth eruption, occlusion and alveolar bone resorption: cytological and cytochemical studies of bone resorption on rat incisor alveolar bone facing the enamel. Arch Histol Cytol 53:497–509CrossRefPubMed Irie K, Ozawa H (1990) Relationships between tooth eruption, occlusion and alveolar bone resorption: cytological and cytochemical studies of bone resorption on rat incisor alveolar bone facing the enamel. Arch Histol Cytol 53:497–509CrossRefPubMed
20.
Zurück zum Zitat Inage T, Shimokawa H, Teranishi Y, Iwase T, Toda Y, Moro I (1989) Immunocytochemical demonstration of amelogenins and enamelins secreted by ameloblasts during the secretory and maturation stages. Arch Histol Cytol 52:213–229CrossRefPubMed Inage T, Shimokawa H, Teranishi Y, Iwase T, Toda Y, Moro I (1989) Immunocytochemical demonstration of amelogenins and enamelins secreted by ameloblasts during the secretory and maturation stages. Arch Histol Cytol 52:213–229CrossRefPubMed
21.
Zurück zum Zitat Mori M, Yamada K, Kasai T, Yamada T, Shimokawa H, Sasaki S (1991) Immunohistochemical expression of amelogenins in odontogenic epithelial tumours and cysts. Virchows Arch A Pathol Anat Histopathol 418:319–325CrossRefPubMed Mori M, Yamada K, Kasai T, Yamada T, Shimokawa H, Sasaki S (1991) Immunohistochemical expression of amelogenins in odontogenic epithelial tumours and cysts. Virchows Arch A Pathol Anat Histopathol 418:319–325CrossRefPubMed
22.
Zurück zum Zitat Fujita S, Hideshima K, Ikeda T (2006) Nestin expression in odontoblasts and odontogenic ectomesenchymal tissue of odontogenic tumours. J Clin Pathol 59:240–245CrossRefPubMed Fujita S, Hideshima K, Ikeda T (2006) Nestin expression in odontoblasts and odontogenic ectomesenchymal tissue of odontogenic tumours. J Clin Pathol 59:240–245CrossRefPubMed
23.
Zurück zum Zitat Miyazaki T, Kanatani N, Rokutanda S, Yoshida C, Toyosawa S, Nakamura R, Takada S, Komori T (2008) Inhibition of the terminal differentiation of odontoblasts and their transdifferentiation into osteoblasts in Runx2 transgenic mice. Arch Histol Cytol 71:131–146CrossRefPubMed Miyazaki T, Kanatani N, Rokutanda S, Yoshida C, Toyosawa S, Nakamura R, Takada S, Komori T (2008) Inhibition of the terminal differentiation of odontoblasts and their transdifferentiation into osteoblasts in Runx2 transgenic mice. Arch Histol Cytol 71:131–146CrossRefPubMed
24.
Zurück zum Zitat Chahine C, Cheung M, Head T, Schwartz S, Glorieux F, Rauch F (2008) Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J Pediatr 153:719–720CrossRefPubMed Chahine C, Cheung M, Head T, Schwartz S, Glorieux F, Rauch F (2008) Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J Pediatr 153:719–720CrossRefPubMed
25.
Zurück zum Zitat Malmgren B, Aström E, Söderhäll S (2008) No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J Oral Pathol Med 37:196–200PubMedCrossRef Malmgren B, Aström E, Söderhäll S (2008) No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J Oral Pathol Med 37:196–200PubMedCrossRef
26.
Zurück zum Zitat Schwartz S, Joseph C, Iera D, Vu D (2008) Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series. J Can Dent Assoc 74:537–542PubMed Schwartz S, Joseph C, Iera D, Vu D (2008) Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series. J Can Dent Assoc 74:537–542PubMed
27.
Zurück zum Zitat Kostenuik P (2009) Inhibition of bone resorption by OPG or alendronate significantly reduced bone growth, molar eruption and tooth root development in neonatal rats. Bone 45:S50CrossRef Kostenuik P (2009) Inhibition of bone resorption by OPG or alendronate significantly reduced bone growth, molar eruption and tooth root development in neonatal rats. Bone 45:S50CrossRef
28.
Zurück zum Zitat Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T (1991) Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173:269–272CrossRefPubMed Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T (1991) Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173:269–272CrossRefPubMed
29.
Zurück zum Zitat Wise GE, Fan W (1989) Changes in the tartrate-resistant acid phosphatase cell population in dental follicles and bony crypts of rat molars during tooth eruption. J Dent Res 68:150–156PubMed Wise GE, Fan W (1989) Changes in the tartrate-resistant acid phosphatase cell population in dental follicles and bony crypts of rat molars during tooth eruption. J Dent Res 68:150–156PubMed
30.
Zurück zum Zitat Tiwana P, Kushner G (2005) Management of impacted teeth in children. Oral Maxillofac Surg Clin North Am 17:365–373CrossRefPubMed Tiwana P, Kushner G (2005) Management of impacted teeth in children. Oral Maxillofac Surg Clin North Am 17:365–373CrossRefPubMed
31.
Zurück zum Zitat Younai F, Eisenbud L, Sciubba J (1988) Osteopetrosis: a case report including gross and microscopic findings in the mandible at autopsy. Oral Surg Oral Med Oral Pathol 65:214–221CrossRefPubMed Younai F, Eisenbud L, Sciubba J (1988) Osteopetrosis: a case report including gross and microscopic findings in the mandible at autopsy. Oral Surg Oral Med Oral Pathol 65:214–221CrossRefPubMed
32.
Zurück zum Zitat Schenk R, Merz WA, Muhlbauer R, Russell RG, Fleisch H (1973) Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196–214CrossRefPubMed Schenk R, Merz WA, Muhlbauer R, Russell RG, Fleisch H (1973) Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196–214CrossRefPubMed
33.
Zurück zum Zitat Sakai H, Takano Y, Ohya K, Kurosaki N (1999) Intermittent inhibition of dentin mineralization of rat incisors under continual infusion of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) using a subcutaneous mini osmotic pump. Arch Histol Cytol 62:171–179CrossRefPubMed Sakai H, Takano Y, Ohya K, Kurosaki N (1999) Intermittent inhibition of dentin mineralization of rat incisors under continual infusion of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) using a subcutaneous mini osmotic pump. Arch Histol Cytol 62:171–179CrossRefPubMed
34.
Zurück zum Zitat Yamada Y, Fuangtharnthip P, Tamura Y, Takagi Y, Ohya K (2000) Gene expression and immunolocalization of amelogenin in enamel hypoplasia induced by successive injections of bisphosphonate in rat incisors. Arch Oral Biol 45:207–215CrossRefPubMed Yamada Y, Fuangtharnthip P, Tamura Y, Takagi Y, Ohya K (2000) Gene expression and immunolocalization of amelogenin in enamel hypoplasia induced by successive injections of bisphosphonate in rat incisors. Arch Oral Biol 45:207–215CrossRefPubMed
Metadaten
Titel
Administration of the Bisphosphonate Zoledronic Acid During Tooth Development Inhibits Tooth Eruption and Formation and Induces Dental Abnormalities in Rats
verfasst von
Toru Hiraga
Tadashi Ninomiya
Akihiro Hosoya
Hiroaki Nakamura
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 6/2010
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-010-9366-z

Weitere Artikel der Ausgabe 6/2010

Calcified Tissue International 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.